Clinical outcomes and predictors of response for adalimumab in patients with moderately to severely active ulcerative colitis: a KASID prospective multicenter cohort study.
Shin SY, Park SJ, Kim Y, Im JP, Kim HJ, Lee KM, Kim JW, Jung SA, Lee J, Kang SB, Shin SJ, Kim ES, Kim YS, Kim TO, Kim HS, Park DI, Kim HK, Kim ES, Kim YH, Kim DH, Teng D, Kim JH, Kim W, Choi CH; IBD Research Group of the Korean Association for the Study of Intestinal Diseases.
Shin SY, et al.
Intest Res. 2022 Jul;20(3):350-360. doi: 10.5217/ir.2021.00049. Epub 2021 Jul 23.
Intest Res. 2022.
PMID: 34289648
Free PMC article.